Pricing

SYQUANT CAPITAL SAS

0 followers ยท
PARIS I0
13F Summary
Syquant Capital SAS is based out of Paris. Their last reported 13F filing for Q4 2023 included $22,157,000 in managed 13F securities and a top 10 holdings concentration of 100.0%. Syquant Capital SAS's largest holding is Mirati Therapeutics Inc with shares held of 153,920. Whalewisdom has at least 21 13F filings

2023-12-31

Top Buys (13F)

Name % Change
MRTX Mirati Therapeutics 40.81%
LAZ Lazard Inc. 32.48%
ICVX Icosavax Inc 13.56%
KRTX Karuna Therapeutics 11.61%
LOGI Logitech Internation 0.58%

2023-12-31

Top Sells (13F)

2023-12-31

13F Holdings Summary

Name $ Change
MRTX Mirati Therapeutics 40.81%
LAZ Lazard Inc. 32.48%
ICVX Icosavax Inc 13.56%
KRTX Karuna Therapeutics 11.61%
LOGI Logitech Internation 0.58%

2023-12-31

13F Activity

Market Value $22.2m, Prior: $255m
New Purchases 7 stocks
Added To 0 stocks
Sold out of 9 stocks
Reduced holdings in 0 stocks
Top 10 Holdings % 100%
Turnover %[1] 228.57%
Turnover Alt %[2] 100%
Time Held Top 20 0 quarters
Time Held Top 10 0 quarters
Time Held All 0.29 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.

2023-12-31

13F Sector Allocation Over Time

2023-12-31

Analysis

Top 20 equal-weighted holdings. Performance numbers calculated through 2023-12-31

Portfolio Performance